−1.72USD
−124.08 MUSD
62.24 M
About Tenaya Therapeutics, Inc.
Sector
CEO
Faraz Ali
Headquarters
South San Francisco
Website
Employees (FY)
140
Founded
2016
ISIN
US87990A1060
FIGI
BBG00FPMK2S3
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TNYA is 4.32 USD — it has increased by 0.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tenaya Therapeutics, Inc. stocks are traded under the ticker TNYA.
Tenaya Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
TNYA stock is 5.49% volatile and has beta coefficient of 2.97. Check out the list of the most volatile stocks — is Tenaya Therapeutics, Inc. there?
One year price forecast for Tenaya Therapeutics, Inc. has a max estimate of 40.00 USD and a min estimate of 7.00 USD.
TNYA earnings for the last quarter are −0.39 USD per share, whereas the estimation was −0.47 USD resulting in a 17.52% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about Tenaya Therapeutics, Inc. earnings.
Yes, you can track Tenaya Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
TNYA stock has fallen by 8.47% compared to the previous week, the month change is a 4.42% fall, over the last year Tenaya Therapeutics, Inc. has showed a 16.13% increase.
TNYA net income for the last quarter is −29.94 M USD, while the quarter before that showed −29.14 M USD of net income which accounts for −2.72% change. Track more Tenaya Therapeutics, Inc. financial stats to get the full picture.
Today Tenaya Therapeutics, Inc. has the market capitalization of 336.83 M, it has increased by 0.87% over the last week.
No, TNYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TNYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tenaya Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 140.00 employees. See our rating of the largest employees — is Tenaya Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tenaya Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tenaya Therapeutics, Inc. stock shows the buy signal. See more of Tenaya Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Tenaya Therapeutics, Inc. future price: according to them, TNYA price has a max estimate of 40.00 USD and a min estimate of 7.00 USD. Read a more detailed Tenaya Therapeutics, Inc. forecast: see what analysts think of Tenaya Therapeutics, Inc. and suggest that you do with its stocks.